ALK — Alkaloid AD Skopje Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapNeutral

Annual income statement for Alkaloid AD Skopje, fiscal year end - December 31st, MKD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	MAS	IFRS	IFRS	IFRS	MAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	12,794	14,289	16,513	19,006	20,899
Cost of Revenue
Gross Profit	5,765	6,454	7,575	8,612	9,412
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	11,315	12,619	14,690	17,014	18,676
Operating Profit	1,479	1,670	1,823	1,992	2,224
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	1,460	1,644	1,786	1,939	2,089
Provision for Income Taxes
Net Income After Taxes	1,305	1,463	1,577	1,684	1,796
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,305	1,463	1,577	1,684	1,796
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,305	1,463	1,577	1,684	1,796
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1,241	1,041	1,122	1,198	1,853
Dividends per Share